Ricerca Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ricerca Biosciences LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7609
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ricerca Biosciences LLC (Ricerca), formerly Ricerca Inc, a subsidiary of Olon SpA, is a contract research organization that offers accelerate drug development services. The organization’s services comprise drug safety and metabolism, chemical development, agrochemicals and other commercial services. Its commercial services comprise analytical chemistry services, specialty chemical manufacturing and aquatic toxicology services. Ricerca’s chemical development services include syntetic chemistry, engineering, and API manufactoring services. The organization serves pharmaceutical, agricultural, chemical, animal nutrition and consumer industries. It collaborates with academia, non-profit organizations, task forces and consultants. Ricerca is headquartered Concord, Ohio, the US.

Ricerca Biosciences LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Main Market Partners Acquires Ricerca Biosciences 10
Asset Transactions 11
Olon Acquires Chemical Division from Ricerca Biosciences 11
WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 12
Eurofins Scientific Completes Acquisition Of Pan Labs Pharmacology Unit From Ricerca Biosciences 13
Acquisition 14
Frontage Laboratories Acquires Concord Biosciences 14
Ricerca Biosciences LLC – Key Competitors 15
Ricerca Biosciences LLC – Key Employees 16
Ricerca Biosciences LLC – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Other Significant Developments 18
Jun 29, 2017: Ricerca Biosciences Renamed to Concord Biosciences After Sale of Chemical Development Division 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Key Facts 2
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ricerca Biosciences LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Main Market Partners Acquires Ricerca Biosciences 10
Olon Acquires Chemical Division from Ricerca Biosciences 11
WIL Research Acquires Pharma Services Business Of Ricerca Biosciences 12
Eurofins Scientific Completes Acquisition Of Pan Labs Pharmacology Unit From Ricerca Biosciences 13
Frontage Laboratories Acquires Concord Biosciences 14
Ricerca Biosciences LLC, Key Competitors 15
Ricerca Biosciences LLC, Key Employees 16

List of Figures
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ricerca Biosciences LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Ricerca Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Simon Property Group Inc (SPG):企業の財務・戦略的SWOT分析
    Simon Property Group Inc (SPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Arcus Biosciences Inc (RCUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Arcus Biosciences Inc (Arcus Biosciences) is a clinical stage bio-pharmaceutical company. The company develops and commercializes cancer immunotherapies. Its product pipeline includes AB928, which is in phase 1/1b trial; AB122 is being developed for cancer patients, is in Phase 1 trial; AB15 …
  • OTE Group:企業の戦略・SWOT・財務分析
    OTE Group - Strategy, SWOT and Corporate Finance Report Summary OTE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Asuragen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that provides laboratory medicine solutions. The company offers products such as amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approv …
  • Acciona SA (ANA):電力:M&Aディール及び事業提携情報
    Summary Acciona SA (Acciona) is a provider of sustainable solutions for infrastructure and renewable energy projects. The company develops and manages infrastructure, renewable energy, water, and other facilities. Its operations cover the whole value chain, from design and construction to operation …
  • MILEI GmbH:戦略・SWOT・企業財務分析
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Concur Technologies, Inc.:企業の戦略的SWOT分析
    Concur Technologies, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Lava Therapeutics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Lava Therapeutics BV (Lava Therapeutics) is a biotechnology company which develops immune oncology biopharmaceuticals products. Its proprietary V?9Vd2 T-cell engager candidates bind to the conserved (monomorphic) T-cell receptor of V?9Vd2 T-cells which exhibit potent cytotoxicity, interferon …
  • PCM Inc:企業の戦略・SWOT・財務情報
    PCM Inc - Strategy, SWOT and Corporate Finance Report Summary PCM Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Commonwealth Scientific and Industrial Research Organisation:医療機器:M&Aディール及び事業提携情報
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • The Scripps Research Institute-医療機器分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • Atnahs Pharma UK Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atnahs Pharma UK Ltd (Atnahs Pharma), a subsidiary of Waymade Plc, is a developer, manufacturer, supplier and distributor of pharmaceutical products. The company provides products such as anacal ointment; dermacort cream; dipentum; gygel, a spermicidal contraceptive, and among others. Atnahs …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fubon Bank (Hong Kong) Ltd:企業の戦略的SWOT分析
    Fubon Bank (Hong Kong) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ironwood Pharmaceuticals Inc (IRWD):製薬・医療:M&Aディール及び事業提携情報
    Summary Ironwood Pharmaceuticals Inc (Ironwood) is a commercial biotechnology company that discovers, develops and commercializes medicines for gastrointestinal disorders. The company's major products include Linzess (linaclotide), an oral capsule for the treatment of irritable bowel syndrome with c …
  • Alder Biopharmaceuticals Inc (ALDR):製薬・医療:M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • INTRUST Financial Corporation:企業の戦略・SWOT・財務情報
    INTRUST Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary INTRUST Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CooperSurgical Inc-医療機器分野:企業M&A・提携分析
    Summary CooperSurgical Inc (CooperSurgical), a subsidiary of The Cooper Companies Inc is a medical device company that offers surgical instrument. The company offers surgical products, clinic and office products, labor and delivery products, and critical care products. Its surgical products include …
  • AB SKF (SKF B)-エネルギー分野:企業M&A・提携分析
    Summary AB SKF (SKF) is a manufacturer and supplier of bearing and seal products that include ball bearings, roller bearings, bearing accessories, truck runner bearings, super-precision bearings, plain bearings, bearing units, bearing housings, and automotive and industrial seal. SKF also offers lub …
  • Malayan Banking Berhad:企業のM&A・事業提携・投資動向
    Malayan Banking Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Malayan Banking Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆